US stocks climbed on potential coronavirus treatment.
US stocks surged higher despite a disapointing GDP report. Investors cheered news Gilead Sciences, a biotech company, said that its potential coronavirus drug remdesivir had positive results in a US study.
The S&P 500 jumped along with the other major indices:
The next potential bullish objective/resistance is the gap fill around 2965. Tuesday's high around 2921 is the first line of defence for the bulls.
Back